Cytokines, chemokines and antibodies against histone-3/4 citrullinated peptides in rheumatoid arthritis patients with pulmonary fibrosis
Abstract Objective Rheumatoid arthritis (RA) associated interstitial lung disease (ILD) is the most common pulmonary manifestations of RA, with a progressive course and a poor survival. An early detection and better treatment is essential to improve outcome. We evaluated 16 analytes that could be re...
Saved in:
| Main Authors: | Linda Johansson, Federico Pratesi, Fosca Errante, Lorenzo Pacini, Paola Migliorini, Solbritt Rantapää-Dahlqvist |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Arthritis Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13075-025-03603-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Citrullinated histone H3 in systemic lupus erythematosus and antiphospholipid syndrome (preliminary results)
by: K. S. Nurbaeva, et al.
Published: (2023-08-01) -
Inhibition of EETosis with an anti-citrullinated histone antibody: a novel therapeutic approach for eosinophilic inflammatory disorders
by: Eline Zwiers, et al.
Published: (2025-02-01) -
Rheumatoid factor and antibodies against cyclic citrullinated peptide in patients without rheumatoid arthritis
by: N. V. Bunchuk
Published: (2023-01-01) -
NETs production and citrullinated histone H3 level in children with tuberculosis
by: D. G. Novikov, et al.
Published: (2025-01-01) -
The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
by: Hui-Chun Yu, et al.
Published: (2019-01-01)